Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids

Journal of Lipid Research

Volumn 56, Issue 2, 2015, Pages 390-402

  Lin, Lauren E ^a   Chen, Chuck T ^a   Hildebrand, Kayla D ^a   Liu, Zhen ^a   Hopperton, Kathryn E ^a   Bazinet, Richard P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Docosahexaenoic acid; Eicosanoid; Kinetics; Metabolism; Polyunsaturated fatty acid

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 6 FATTY ACID; ICOSANOID; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPLETION; DOCOSAHEXAENOIC ACID METABOLISM; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID BRAIN LEVEL; FATTY ACID DEPLETION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; HALF LIFE TIME; LIPID BRAIN LEVEL; LIPID STORAGE; MALE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; QUANTITATIVE STUDY; RAT; ANIMAL; BRAIN; DEFICIENCY; KINETICS; METABOLISM;

ANIMALS; ARACHIDONIC ACID; BRAIN; DOCOSAHEXAENOIC ACIDS; EICOSANOIDS; FATTY ACIDS, OMEGA-6; KINETICS; MALE; PHOSPHOLIPIDS; RATS;

EID: 84921944691     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M055590     Document Type: Article

References (52)

1. Ramsden, C. E., K. R. Faurot, D. Zamora, C. M. Suchindran, B. A. Macintosh, S. Gaylord, A. Ringel, J. R. Hibbeln, A. E. Feldstein, T. A. Mori, et al. 2013. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain. 154 : 2441-2451
2. Attwell, D., A. M. Buchan, S. Charpak, M. Lauritzen, B. A. Macvicar , and E. A. Newman. 2010. Glial and neuronal control of brain blood fl ow. Nature. 468 : 232-243
3. Bazan, N. G., M. F. Molina, and W. C. Gordon. 2011. Docosahexaenoic acid signalolipidomics in nutrition: signifi cance in aging, neuroinfl ammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 31 : 321-351
4. Bazan, N. G. 2003. Synaptic lipid signaling: signifi cance of polyunsaturated fatty acids and platelet-Activating factor. J. Lipid Res. 44 : 2221-2233
5. Serhan, C. N., and N. A. Petasis. 2011. Resolvins and protectins in infl ammation resolution. Chem. Rev. 111 : 5922-5943
6. Orr, S. K., and R. P. Bazinet. 2008. The emerging role of docosahexaenoic acid in neuroinfl ammation. Curr. Opin. Investig. Drugs. 9 : 735-743
7. Rapoport, S. I. 2008. Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins Leukot. Essent. Fatty Acids. 79 : 153-156
8. Yakunin, E., V. Loeb, H. Kisos, Y. Biala, S. Yehuda, Y. Yaari, D. J. Selkoe, and R. Sharon. 2012. Alpha-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease. Brain Pathol. 22 : 280-294
9. Bazinet, R. P., and S. Laye. 2014. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 15 : 771-785
10. DeMar, J. C., Jr ., K. Ma, J. M. Bell, and S. I. Rapoport. 2004. Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91 : 1125-1137
11. Green, J. T., Z. Liu, and R. P. Bazinet. 2010. Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet. J. Lipid Res. 51 : 535-543
12. Kim, H. W., J. S. Rao, S. I. Rapoport, and M. Igarashi. 2011. Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation. Prostaglandins Leukot. Essent. Fatty Acids. 85 : 361-368
13. Rao, J. S., R. N. Ertley, J. C. DeMar, Jr ., S. I. Rapoport, R. P. Bazinet , and H. J. Lee. 2007. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry. 12 : 151-157
14. Contreras, M. A., R. S. Greiner, M. C. Chang, C. S. Myers, N. Salem , Jr ., and S. I. Rapoport. 2000. Nutritional deprivation of alphalinolenic acid decreases but does not abolish turnover and availability of unacylated docosahexaenoic acid and docosahexaenoyl-CoA in rat brain. J. Neurochem. 75 : 2392-2400
15. Igarashi, M., F. Gao, H. W. Kim, K. Ma, J. M. Bell, and S. I. Rapoport. 2009. Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim. Biophys. Acta. 1791 : 132-139
16. Kim, H. W., J. S. Rao, S. I. Rapoport, and M. Igarashi. 2011. Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. Biochim. Biophys. Acta. 1811 : 111-117
17. Igarashi, M., H. W. Kim, L. Chang, K. Ma, and S. I. Rapoport. 2012. Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain. J. Neurochem. 120 : 985-997
18. Chen, C. T., M. O. Trepanier, K. E. Hopperton, A. F. Domenichiello , M. Masoodi, and R. P. Bazinet. 2014. Inhibiting mitochondrial beta-oxidation selectively reduces levels of nonenzymatic oxidative polyunsaturated fatty acid metabolites in the brain. J. Cereb. Blood Flow Metab. 34 : 376-379
19. Domenichiello, A. F., C. T. Chen, M. O. Trepanier, P. M. Stavro , and R. P. Bazinet. 2014. Whole body synthesis rates of DHA from alpha-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats. J. Lipid Res. 55 : 62-74
20. Trépanier, M. O., J. Lim, T. K. Lai, H. J. Cho, A. F. Domenichiello , C. T. Chen, A. Y. Taha, R. P. Bazinet, and W. M. Burnham. 2014. Intraperitoneal administration of docosahexaenoic acid for 14days increases serum unesterifi ed DHA and seizure latency in the maximal pentylenetetrazol model. Epilepsy Behav. 33 : 138-143
21. Trépanier, M. O., A. Y. Taha, R. L. Mantha, F. A. Ciobanu, Q. H. Zeng, G. M. Tchkhartichvili, A. F. Domenichiello, R. P. Bazinet , and W. M. Burnham. 2012. Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses. Epilepsy Res. 99 : 225-232
22. Reeves, P. G., K. L. Rossow, and J. Lindlauf. 1993. Development and testing of the AIN-93 purifi ed diets for rodents: results on growth, kidney calcifi cation and bone mineralization in rats and mice. J. Nutr. 123 : 1923-1931
23. Reeves, P. G., F. H. Nielsen, and G. C. Fahey, Jr. 1993. AIN-93 purifi ed diets for laboratory rodents: fi nal report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 : 1939-1951
24. Cunnane, S. C., and P. Guesnet. 2011. Linoleic acid recommendations-A house of cards. Prostaglandins Leukot. Essent. Fatty Acids. 85 : 399-402
25. Bourre, J. M., M. Piciotti, O. Dumont, G. Pascal, and G. Durand. 1990. Dietary linoleic acid and polyunsaturated fatty acids in rat brain and other organs. Minimal requirements of linoleic acid. Lipids. 25 : 465-472
26. Chen, C. T., Z. Liu, and R. P. Bazinet. 2011. Rapid de-esterifi cation and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J. Neurochem. 116 : 363-373
27. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purifi cation of total lipides from animal tissues. J. Biol. Chem. 226 : 497-509
28. Chen, C. T., Z. Liu, M. Ouellet, F. Calon, and R. P. Bazinet. 2009. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot. Essent. Fatty Acids. 80 : 157-163
29. Chen, C. T., M. O. Trepanier, K. E. Hopperton, A. F. Domenichiello , M. Masoodi, and R. P. Bazinet. 2014. Inhibiting mitochondrial beta-oxidation selectively reduces levels of nonenzymatic oxidative polyunsaturated fatty acid metabolites in the brain. J. Cereb. Blood Flow Metab. 34 : 376-379
30. Aveldano, M. I., M. VanRollins, and L. A. Horrocks. 1983. Separation and quantitation of free fatty acids and fatty acid methyl esters by reverse phase high pressure liquid chromatography. J. Lipid Res. 24 : 83-93
31. Igarashi, M., K. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and J. C. DeMar, Jr. 2006. Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoatecontaining diet. J. Lipid Res. 47 : 1812-1822
32. Stinson, A. M., R. D. Wiegand, and R. E. Anderson. 1991. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid defi-ciency. J. Lipid Res. 32 : 2009-2017
33. Chen, C. T., A. F. Domenichiello, M. O. Trepanier, Z. Liu, M. Masoodi, and R. P. Bazinet. 2013. The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. J. Lipid Res. 54 : 2410-2422
34. Robinson, P. J., J. Noronha, J. J. DeGeorge, L. M. Freed, T. Nariai , and S. I. Rapoport. 1992. A quantitative method for measuring regional in vivo fatty-Acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17 : 187-214
35. Chen, C. T., and R. P. Bazinet. 2014. Beta-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins Leukot. Essent. Fatty Acids. Epub ahead of print June 5, 2014. pii: S0952-3278(14)00083-0. doi: 10.1016/j. plefa.2014.05.007
36. Svennerholm, L. 1968. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J. Lipid Res. 9 : 570-579
37. Igarashi, M., K. Ma, F. Gao, H. W. Kim, D. Greenstein, S. I. Rapoport, and J. S. Rao. 2010. Brain lipid concentrations in bipolar disorder. J. Psychiatr. Res. 44 : 177-182
38. Chen, C. T., D. W. Ma, J. H. Kim, H. T. Mount, and R. P. Bazinet. 2008. The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations. J. Lipid Res. 49 : 147-152
39. Trushenski, J., M. Schwarz, A. Bergman, A. Rombenso, and B. Delbos. 2012. DHA is essential, EPA appears largely expendable, in meeting the n 3 long-chain polyunsaturated fatty acid requirements of juvenile cobia Rachycentron canadum. Aquaculture. 326-329 : 81-89
40. Martins, J. G., H. Bentsen, and B. K. Puri. 2012. Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with effi cacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-Analysis. Mol Psychiatry 17 : 1144-1149 ; discussion 1163-1167
41. Martins, J. G. 2009. EPA but not DHA appears to be responsible for the effi cacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-Analysis of randomized controlled trials. J. Am. Coll. Nutr. 28 : 525-542
42. Goodgame, J. T., S. F. Lowry, and M. F. Brennan. 1978. Essential fatty acid defi ciency in total parenteral nutrition: time course of development and suggestions for therapy. Surgery. 84 : 271-277
43. Wene, J. D., W. E. Connor, and L. DenBesten. 1975. The development of essential fatty acid defi ciency in healthy men fed fat-free diets intravenously and orally. J. Clin. Invest. 56 : 127-134
44. Collins, F. D., A. J. Sinclair, J. P. Royle, D. A. Coats, A. T. Maynard , and R. F. Leonard. 1971. Plasma lipids in human linoleic acid defi-ciency. Nutr. Metab. 13 : 150-167
45. Cunnane, S. C. 2003. Problems with essential fatty acids: time for a new paradigm? Prog. Lipid Res. 42 : 544-568
46. Burr, G. O., and M. M. Burr. 1929. A new defi ciency disease produced by the rigid exclusion of fat from the diet. J. Biol. Chem. 82 : 345-367
47. Burr, G. O., and M. M. Burr. 1930. On the nature and role of the fatty acids essential in nutrition. J. Biol. Chem. 86 : 587-621
48. Holman, R. T. 1958. Essential fatty acids. Nutr. Rev. 16 : 33-35
49. Guesnet, P., S. M. Lallemand, J. M. Alessandri, M. Jouin, and S. C. Cunnane. 2011. alpha-Linolenate reduces the dietary requirement for linoleate in the growing rat. Prostaglandins Leukot. Essent. Fatty Acids. 85 : 353-360
50. Lucas, M., F. Mirzaei, E. J. O'Reilly, A. Pan, W. C. Willett, I. Kawachi , K. Koenen, and A. Ascherio. 2011. Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am. J. Clin. Nutr. 93 : 1337-1343
51. Rao, J. S., H. J. Lee, S. I. Rapoport, and R. P. Bazinet. 2008. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol. Psychiatry. 13 : 585-596
52. Rapoport, S. I. 2014. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. ACS Chem. Neurosci. 5 : 459-467